Hi All,
I am working on conjugating Anti-EGFR antibodies to the surface of PLGA-PEG-maleimide nanoparticles to target tumor cells over-expressing EGFR.
My question is approximately what ratio of mAB to nanoparticle should I aim for in order to achieve good targeting. Does anyone have experience here they would like to share?
All help is greatly appreciated!
EF